Arcadia Biosciences Inc [RKDA] stock prices are up 10.48% to $3.69 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The RKDA shares have gain 9.17% over the last week, with a monthly amount glided 6.65%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Arcadia Biosciences Inc [NASDAQ: RKDA] stock has seen the most recent analyst activity on August 17, 2020, when H.C. Wainwright reiterated its Buy rating and also revised its price target to $12 from $14. Previously, Piper Jaffray downgraded its rating to Neutral on May 12, 2017. On June 09, 2015, Piper Jaffray initiated with a Overweight rating and assigned a price target of $10 on the stock. Credit Suisse started tracking the stock assigning a Outperform rating and suggested a price target of $14 on June 09, 2015.
The stock price of Arcadia Biosciences Inc [RKDA] has been fluctuating between $2.53 and $10.31 over the past year. Currently, Wall Street analysts expect the stock to reach $6 within the next 12 months. Arcadia Biosciences Inc [NASDAQ: RKDA] shares were valued at $3.69 at the most recent close of the market. An investor can expect a potential return of 62.6% based on the average RKDA price forecast.
Analyzing the RKDA fundamentals
The Arcadia Biosciences Inc [NASDAQ:RKDA] reported sales of 5.41M for trailing twelve months, representing a surge of 11.41%. Gross Profit Margin for this corporation currently stands at 0.38% with Operating Profit Margin at -1.07%, Pretax Profit Margin comes in at -1.31%, and Net Profit Margin reading is -1.39%. To continue investigating profitability, this company’s Return on Assets is posted at -0.97, Equity is -1.01 and Total Capital is -0.97. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It’s worth pointing out that Arcadia Biosciences Inc [NASDAQ:RKDA]’s Current Ratio is 4.12. Also, the Quick Ratio is 3.31, while the Cash Ratio stands at 0.75. Considering the valuation of this stock, the price to sales ratio is 0.93, the price to book ratio is 1.11.
Transactions by insiders
Recent insider trading involved Kawakami Mark, Chief Financial Officer, that happened on Feb 03 ’25 when 700.0 shares were purchased. Chief Executive Officer, Schaefer Thomas J. completed a deal on Feb 03 ’25 to buy 700.0 shares.
